Australia Markets close in 1 hr 37 mins

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.72+0.31 (+2.31%)
At close: 04:00PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    uniQure Announces FDA Acceptance of Biologics License Application for Etranacogene Dezaparvovec under Priority Review

    If approved, etranacogene dezaparvovec would be the first gene therapy option for people living with hemophilia BLEXINGTON, Mass. and AMSTERDAM, May 24, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) submitted by CSL Behring for etranacogene dezapar

  • GlobeNewswire

    uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    LEXINGTON, Mass. and AMSTERDAM, May 11, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the Company granted equity awards to 32 newly hired employees as a material inducement to commencing their employment. The equity grants were approved on April 29, 2022 (the “Grant Date”) in accordance with Nasdaq Listing Rule 5635(c)(4). In the aggregate, the employees received

  • Simply Wall St.

    Things Look Grim For uniQure N.V. (NASDAQ:QURE) After Today's Downgrade

    One thing we could say about the analysts on uniQure N.V. ( NASDAQ:QURE ) - they aren't optimistic, having just made a...